SCHEMBL9601440

SCHEMBL9601440

CCCCCN1C(=O)c2ccccc2CC1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ CDC25A P30304 10/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ ALDH2 P05091 1/20 0.41
▸ ALDH3A1 P30838 1/20 0.41
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCD Q05655 1/20 0.40
▸ CES1 P23141 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9812654 0.83 PRKCG (0.50) PRKCGPRKCBPRKCAPRKCHPRKCE
SCHEMBL2159859 0.83 PRKCG (0.50) PRKCGPRKCBPRKCAPRKCHPRKCE
SCHEMBL8427694 0.82 PRKCD (0.52) PRKCGPRKCBPRKCAPRKCHPRKCE
SCHEMBL9812649 0.79 ACE (0.49) —
SCHEMBL9812655 0.79 ACE (0.49) —
SCHEMBL8498408 0.78 CAPN1 (0.56) CAPN1POLBALDH1A1KDM4EALOX15
SCHEMBL10855534 0.78 CAPN1 (0.56) CAPN1POLBALDH1A1KDM4EALOX15
SCHEMBL10854074 0.78 CAPN1 (0.56) CAPN1POLBALDH1A1KDM4EALOX15
SCHEMBL3804693 0.72 SMN1; SMN2 (0.47) CAPN1POLBKMT2AALDH1A1KDM4E
SCHEMBL7536950 0.70 ACE (0.49) POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238935-A Treating atherosclerosis SCHERING CORPORATION (US) 1993-08-24 — — US disclosed
EP-0514851-A1 N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase SCHERING CORPORATION (US) 1992-11-25 — — EP disclosed
US-5124337-A Treating atherosclerosis SCHERING CORPORATION (US) 1992-06-23 — — US disclosed
Send feedback